发明名称 TREATMENT OF AUTISM SPECTRUM DISORDERS USING GLYCYL-L-2-METHYLPROPYL-L-GLUTAMIC ACID
摘要 PROBLEM TO BE SOLVED: To provide compounds, compositions, and methods for treating autism spectrum disorder (ASD) using glycyl-2-methylpropyl-glutamic acid (G-2-MePE) and analogs thereof, the autism spectrum disorder including Autism, Autistic Disorder, Asperger Syndrome, Childhood Disintegrative Disorder, Pervasive Developmental Disorder - Not Otherwise Specified (PDD-NOS), Fragile X Syndrome, and Rett Syndrome.SOLUTION: Compositions containing G-2-MePE and analogs thereof include water-soluble formulations, water-in-oil micro-emulsions, water-in-oil coarse emulsions, water-in-oil liquid crystals, nanocapsules, tablets, and orally administered gels. The compounds and compositions of this invention can be administered intravenously, intraventricularly, parenterally, or orally, and can be effective in treating neurodegeneration, promoting neurological function, treating seizure activity and other symptoms of ASD, and can prolong life in animals including human beings having Autism Spectrum Disorders.SELECTED DRAWING: None
申请公布号 JP2016210808(A) 申请公布日期 2016.12.15
申请号 JP20160176567 申请日期 2016.09.09
申请人 NEUREN PHARMACEUTICALS LTD 发明人 LARRY GLASS;MICHAEL JOHN BICKERDIKE;MICHAEL FREDERICK SNAPE
分类号 A61K38/00;A61K9/06;A61K9/08;A61K9/107;A61K9/20;A61K9/48;A61K45/00;A61P25/28;A61P43/00 主分类号 A61K38/00
代理机构 代理人
主权项
地址